Literature DB >> 6484806

Searching for the best weight reduction operation.

R D Rucker, E K Chan, J Horstmann, E P Chute, R L Varco, H Buchwald.   

Abstract

At the University of Minnesota under the supervision of one staff surgeon both jejunoileal bypass (JIB) and gastric bypass (GIB) operations have been performed for weight reduction in morbidly obese individuals. During the last 14 years 727 patients underwent end-to-end (40 to 4 cm) JIB and more than 570 patients underwent GIB. This report is based on a comparison of 205 JIBs performed between July 1975 and July 1979, 106 Alden-loop type GIBs (GIB-loop) performed between July 1975 and July 1979, 53 loop GIBs with enteroenterostomies between the limbs of the loop (GIB-EE) performed between May 1980 and May 1981, and 57 Roux-en-Y GIBs (GIB-Roux) performed between May 1981 and May 1982. Adequate weight loss occurred in 80% of the patients who returned for follow-up in all groups. The percentage of excess body weight loss was similar for the first year (65% for JIB, 62% for GIB-loop, 69% for GIB-EE, and 71% for GIB-Roux). The operative mortality and the immediate morbidity rates were uniformly low. The long-term complications for JIB were 37.7% arthralgia, 7.1% oxalate urolithiasis, 5.6% incisional hernia, and 1.4% liver failure. The complications for GIB-loop were 10.2% nausea/vomiting, 1.9% bile reflux gastritis, and 2.8% anastomotic problems; for GIB-EE 23% nausea/vomiting, 7% bile gastritis, 4.6% incisional hernia, and 3.7% anastomotic problems; and for GIB-Roux 16% nausea/vomiting and 1.7% anastomotic problems. The anastomotic problems consisted of afferent loop obstructions and stomal stenosis; there were no leaks. At 1 year plasma cholesterol reduction for JIB averaged 42% (p less than 0.001), GIB-loop 14% (p less than 0.001), GIB-EE 7% (NS), and GIB-Roux 17% (p less than 0.001). One year after operation 49% of 88 JIB patients showed progression of liver disease on sequential biopsy specimens and 20% improvement. In the 78 GIB patients with sequential biopsies, liver disease progressed in 8% and improved in 65%. In summary, comparable therapeutic weight reduction occurred with all the assessed procedures; however, the GIB-Roux was associated with far fewer serious long-term complications. At this time the GIB-Roux procedure is the weight reduction operation we recommend.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6484806

Source DB:  PubMed          Journal:  Surgery        ISSN: 0039-6060            Impact factor:   3.982


  5 in total

Review 1.  Bariatric surgery evolution from the malabsorptive to the hormonal era.

Authors:  Ehab Akkary
Journal:  Obes Surg       Date:  2012-05       Impact factor: 4.129

2.  [Results and critical analysis of the treatment of obesity with the intragastric balloon].

Authors:  O Abri; I Schwenger-Holst; L M Hermanns; E Kraas; W Schairer
Journal:  Langenbecks Arch Chir       Date:  1988

3.  Long-term consequences after jejunoileal bypass for morbid obesity.

Authors:  M P Hocking; G L Davis; D A Franzini; E R Woodward
Journal:  Dig Dis Sci       Date:  1998-11       Impact factor: 3.199

4.  [Therapeutic failures after gastric bypass operations for morbid obesity].

Authors:  S Kriwanek; P Beckerhinn; W Blauensteiner; K Dittrich; C Armbruster
Journal:  Langenbecks Arch Chir       Date:  1995

5.  Resolution of nonalcoholic steatohepatits after gastric bypass surgery.

Authors:  Xiuli Liu; Audrey J Lazenby; Ronald H Clements; Nirag Jhala; Gary A Abrams
Journal:  Obes Surg       Date:  2007-04       Impact factor: 4.129

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.